Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2010 / Cilt: 24 - Sayı: 2

Cutaneous signs observed in diabetes mellitus patients

Diyabetes mellituslu hastalarda gözlenen deri bulguları

Pages
77–80
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we found that the most common cutaneous sign was infection and the most common systemic complication was hypertension in DM patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aims to investigate cutaneous signs observed in patients with diabetes mellitus (DM).
📊
Key Findings & Data:The study registered a total of 175 DM patients, 163 type II DM and 12 type I DM, who were inpatients in the Endocrinology Service of Fırat University.
💡
Conclusion & Impact:In conclusion, we found that the most common cutaneous sign was infection and the most common systemic complication was hypertension in DM patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This study aims to investigate cutaneous signs observed in patients with diabetes mellitus (DM). The study registered a total of 175 DM patients, 163 type II DM and 12 type I DM, who were inpatients in the Endocrinology Service of Fırat University. Anamneses of the patients were obtained and cutaneous and systemic signs of the patients were photographed and recorded. Skin biopsy was taken for histopathologic examination, when necessary; scrapings were taken from lesions where fungal infection was suspected for native preparation examination; bacterial culture and antibiogram examinations were carried out in lesions where bacterial infection was suspected. This study included a total of 175 adult DM patients whose age ranged between 18 and 89 and of whom 110 (62.9%) were female and 65 (37.1%) were male. Mean age of the patients was 56.88±14.8 years. Duration of the disease varied between 1 and 36 years. Of the patients, 151 (86.28%) had at least one cutaneous sign. The most common cutaneous sign was infection (43.4%), which included 57 (32.6%) dermatophyte, 10 (5.7%) bacterial infection, 7 (4%) candidiasis and 2 (1.1%) herpes labialis in order of frequency. The second most common sign was xerosis (40%), and the most frequent complaint reported by the patients was itching (20%). The most commonly observed systemic complication was hypertension (61.7%). While the average duration of illness of the patients with compliceted diabetes were 11.64±7:33 years who did not develop complications were 9:06±8:11. The differences between disease duration and presence of complications were statistically significant (p = 0.04). While the mean age of patients with compliceted diabetes were 59.79 ±12.62 years who did not develop complications were 51.44±17:07 years. There was a statistically significant relationships between the average age and the presence of complications (p=0.01). In conclusion, we found that the most common cutaneous sign was infection and the most common systemic complication was hypertension in DM patients.

Özet

Bu çalışmanın amacı diyabetes mellituslu (DM) hastalarda gözlenen deri bulgularını araştırmaktır. Çalışmaya Fırat Üniversitesi Endokrinoloji servisinde yatarak tedavi görmekte olan 163’ü tip 2 DM ve 12’si tip 1 DM olmak üzere toplam 175 DM’li hasta alındı. Hastaların anamnezleri alınarak, cilt ve sistemik bulguları kaydedildi ve fotoğraflandı. Gerekli durumlarda cilt biyopsisi alınarak histopatolojik inceleme yapıldı, fungal enfeksiyon düşünülen lezyonlardan kazıntı alınarak nativ preparat inceleme yapıldı, bakteriyel enfeksiyon düşünülen lezyonlardan bakteriyel kültür ve antibiyogram incelemesi yapıldı. Bu çalışmaya 18-89 yaşları arasında 110 (%62.9) kadın ve 65 (%37.1) erkek olmak üzere toplam 175 DM’li erişkin hasta alındı. Hastaların yaş ortalaması 56.88±14.8 yıl idi. Hastalık süresi 1-36 yıl arasında değişmekteydi. Hastaların 151’inde (%86.28) en az bir deri bulgusu mevcuttu. Diyabetik hastalarda gözlenen en önemli deri bulgusu enfeksiyon hastalıkları (%43.4) olup; 57 (%32.6) dermatofit, 10 (%5.7) bakteriyel enfeksiyon, 7 (%4) kandidiyazis ve 2 (%1.1) herpes labiyalis enfeksiyonu şeklinde sıralanmaktaydı. İkinci sıklıkta gözlenen bulgu kserozis (%40) ve hastalar tarafından en sık bildirilen semptom kaşıntı (%20) idi. En sık gözlenen sistemik komplikasyon ise hipertansiyondu (%61.7). Diyabete bağlı sistemik komplikasyon gelişen hastaların ortalama hastalık süresi 11.64±7.33 yıl olup, sistemik komplikasyon gelişmemiş olan hastaların hastalık süresi 9.06±8.11 yıl idi. Komplikasyon varlığı ile hastalık süresi arasındaki bu farklılık istatistiksel olarak anlamlı bulundu (p=0.04). Sistemik komplikasyon mevcut olan hastaların ortalama yaşı 59.79±12.62 yıl olup, komplikasyon gelişmemiş olan hastaların ortalama yaşı 51.44±17.07 yıl idi. Sistemik komplikasyon varlığı ile ortalama yaş arasında istatistiksel olarak anlamlı ilişki saptandı (p=0.01). Sonuç olarak DM’li hastalarda gözlenen en sık deri bulgusunun enfeksiyon ve en sık sistemik komplikasyonun ise hipertansiyon olduğunu saptadık.

🔖

Cite This Article

ÇİÇEK, D., HALİSDEMİR, N., ÖZKAN, Y., ÇOLAK, R., KANDİ, B., DERTLİOĞLU, B. S., OĞUZ, S. (2022). Cutaneous signs observed in diabetes mellitus patients. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 24 - Sayı: 2, 77–80. https://ajindex.com/articles/514748

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kostler E, Porst H, Wollina U. Cutaneous manifestations of metabolic diseases: uncommon presentations. Clinics in Dermatology 2005; 23: 457–464
  2. Levin NA, Greer KE. Cutaneous manifestations of endocrine disorders. Dermatology nursing 2001; 3: 185- 196
  3. Ngo BT, Hayes KD, DiMiao DJ, et al. Manifestations of Cutaneous Diabetic Microangiopathy. Am J Clin Dermatol 2005; 4: 225-237
  4. Satman I, Yilmaz T, Sengül A, et al. Population-based study of diabetes and risk characteristics in Turkey: Results of the Turkish diabetes epidemiyology study (TURDEP). Diabetes Care 2002; 25: 1551-1556
  5. Borch-Johnsen K. The new classification of diabetes mellitus and IGT: a critical approach. Exp Clin Endocrinol Diabetes 2001;109: 86-93
  6. Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial: a randomized, controlled trial. Ann Intern Med 1998;128: 517-523
  7. Ferringer T, Miller F. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 2002; 3: 483-492
  8. Huntley AC. The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982; 4: 427-455
  9. Saray Y, Özcan D, Seçkin D. Tip II Diabetes Mellituslu Hastalarda Deri Bulguları. Turkiye Klinikleri Journal of Medical Sciences 2005; 25: 377-382
  10. Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. American Journal of Clinical Dermatology 2003; 4: 315-331
  11. Özata M, Yönem A. Diyabetes Mellitus Tanısı, sınıflaması, klinik özellikler Endokrinoloji-Metabolizma ve Diyabet Kitabı. 1.Baskı, İstanbul: Medikal Yayıncılık, 2006: 275- 283
  12. Al-Mutairi N, Zaki A, Sharma AK, et al. Cutaneous manifestations of diabetes mellitus. Study from Farwaniya hospital, Kuwait. Med Princ Pract 2006; 15: 427-430
  13. Wang YR, Margolis D. The Prevalence of Diagnosed Cutaneous Manifestations during Ambulatory Diabetes Visits in the United States, 1998–2002. Dermatology 2006; 212: 229–234
  14. Pavlović MD, Milenković T, Dinić M, et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care 2007; 30: 1964-1967
  15. Nigam PK, Pande S. Pattern of dermatoses in diabetics. Indian J Dermatol Venereol Leprol 2003; 69: 83–85
  16. Mahajan S, Koranne RV, et al. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol 2003; 69: 105–108
  17. Yosipovitch G, Hodak E, Vardi P, et al. The prevale